###begin article-title 0
###xml 177 178 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 178 178 169 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2"/>
###xml 178 180 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">S&#8414;</xref>
Silencing of the Transforming Growth Factor-beta (TGFbeta) Receptor II by Kruppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGFbeta Signaling*Sâƒž
###end article-title 0
###begin p 1
###xml 17 21 <span type="species:ncbi:162683">Mayo</span>
Supported by the Mayo Clinic Clinician Investigator Training Program and the Dept. of Surgery.
###end p 1
###begin p 2
###xml 58 62 <span type="species:ncbi:162683">Mayo</span>
###xml 167 171 <span type="species:ncbi:162683">Mayo</span>
###xml 232 236 <span type="species:ncbi:162683">Mayo</span>
Supported by National Institute of Health Grant CA125127, Mayo Clinic Pancreatic SPORE Career Development Award (Grant P50 CA102701), in honor of Carole and Bob Daly, Mayo Clinic Cancer Center, and the Division of Gastroenterology (Mayo Clinic College of Medicine).
###end p 2
###begin p 3
###xml 177 198 177 198 <email xmlns:xlink="http://www.w3.org/1999/xlink">urrutia.raul@mayo.edu</email>
###xml 96 100 <span type="species:ncbi:162683">Mayo</span>
###xml 190 194 <span type="species:ncbi:162683">mayo</span>
 To whom correspondence should be addressed: 200 First St. SW, GI Research Unit, Guggenheim 10, Mayo Clinic, Rochester, MN 55905. Tel.: 507-255-6029; Fax: 507-255-6318; E-mail: urrutia.raul@mayo.edu. 
###end p 3
###begin p 4
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 4
###begin p 5
 applies to Author Choice Articles
###end p 5
###begin p 6
###xml 269 272 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 276 279 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 680 683 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 687 690 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 885 888 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 892 895 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1139 1142 1106 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1146 1149 1110 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1329 1332 1290 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1336 1339 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
The role of non-Smad proteins in the regulation of transforming growth factor-beta (TGFbeta) signaling is an emerging line of active investigation. Here, we characterize the role of KLF14, as a TGFbeta-inducible, non-Smad protein that silences the TGFbeta receptor II (TGFbetaRII) promoter. Together with endocytosis, transcriptional silencing is a critical mechanism for down-regulating TGFbeta receptors at the cell surface. However, the mechanisms underlying transcriptional repression of these receptors remain poorly understood. KLF14 has been chosen from a comprehensive screen of 24 members of the Sp/KLF family due to its TGFbeta inducibility, its ability to regulate the TGFbetaRII promoter, and the fact that this protein had yet to be functionally characterized. We find that KLF14 represses the TGFbetaRII, a function that is augmented by TGFbeta treatment. Mapping of the TGFbetaRII promoter, in combination with site-directed mutagenesis, electromobility shift, and chromatin immunoprecipitation assays, have identified distinct GC-rich sequences used by KLF14 to regulate this promoter. Mechanistically, KLF14 represses the TGFbetaRII promoter via a co-repressor complex containing mSin3A and HDAC2. Furthermore, the TGFbeta pathway activation leads to recruitment of a KLF14-mSin3A-HDAC2 repressor complex to the TGFbetaRII promoter, as well as the remodeling of chromatin to increase histone marks that associate with transcriptional silencing. Thus, these results describe a novel negative-feedback mechanism by which TGFbetaRII activation at the cell surface induces the expression of KLF14 to ultimately silence the TGFbetaRII and further expand the network of non-Smad transcription factors that participate in the TGFbeta pathway.
###end p 6
###begin p 7
###xml 82 90 <span type="species:ncbi:9606">patients</span>
We dedicate this manuscript to the memory of Kazimierz Truty and to all the other patients who have succumbed to pancreatic cancer.
###end p 7
###begin p 8
###xml 49 78 49 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 85 93 85 93 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">DK 52913</grant-num>
###xml 127 155 127 155 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Mayo Clinic Pancreatic SPORE</grant-sponsor>
###xml 163 175 163 175 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">P50 CA102701</grant-num>
###xml 328 341 328 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
###xml 127 131 <span type="species:ncbi:162683">Mayo</span>
This work was supported, in whole or in part, by National Institutes of Health Grant DK 52913. This work was also supported by Mayo Clinic Pancreatic SPORE (Grant P50 CA102701 to R. U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 9
###begin p 10
The on-line version of this article (available at ) contains supplemental Table S1.
###end p 10
###begin p 11
###xml 44 45 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">4</xref>
###xml 255 256 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 257 259 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 702 703 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 705 706 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
The family of cytokines composed of TGFbeta,4 bone morphogenetic proteins, activins, inhibins, connective tissue growth factors (CCN family), along with their corresponding signaling molecules, are master regulators of normal homeostasis and development (1-10). Consequently, alterations in these pathways lead to severe malformations and diseases, including cancer. TGFbeta is the best characterized pathway within this family of cytokines. Recent studies reveal, for instance, the existence of two types of membrane-to-nucleus TGFbeta signaling mechanisms, namely the Smad-dependent and non-Smad protein-mediated cascades, although evidence of cross-talk between these two cascades is also emerging (4, 9). Therefore, even though our understanding of the complexity underlying TGFbeta signaling continues to grow, classification into these two types of mechanisms has helped to organize the nascent theoretical framework for advancing this field of research by the integration of new findings into easily understandable paradigms.
###end p 11
###begin p 12
###xml 341 342 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
The canonical Smad-mediated TGFbeta pathway is activated by binding of TGFbeta1, -2, and/or -3 cytokines to the TGFbetaRII, which then dimerizes with and activates the TGFbeta receptor I through serine phosphorylation of the regulatory GS-domain. The Type I receptor, in turn, phosphorylates receptor-bound Smad (Smad2/3) at the C-terminal SXS motif, releasing them from retention in the cytoplasm and allowing their translocation into the nucleus. Smad4 acts as a common partner of activated Smads to help execute their function. In this manner, TGFbeta signaling is transduced through the cytoplasm into the nucleus to form complexes with distinct transcriptional regulators for specific gene promoters.
###end p 12
###begin p 13
###xml 529 530 526 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 533 534 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 682 684 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 685 687 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 935 937 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 938 940 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
The role of non-Smad protein-mediated pathways in the regulation of TGFbeta signaling is also an active line of investigation. For instance, the Sp/KLF family of proteins is emerging as important non-Smad protein-mediated pathway cascades and, under certain circumstances, a cross-talk regulator with Smads to achieve distinct cellular functions. Sp1 is the founding member this expanding group of Sp/KLF proteins. The structure of these proteins is defined by the presence of three highly conserved and homologous C-terminal Cys2His2 zinc finger domains, which are responsible for DNA binding, and a variable N-terminal domain, which is responsible for transcriptional regulation (11-13). However, the identification and characterization of this family of proteins has revealed that many bind to GC-rich target sequences similar, if not identical to, the "Sp1 sites" through which they can either activate or repress gene expression (11-13). Therefore, the discovery of repressors within this Sp/KLF family of transcriptional regulators has challenged the early paradigm that Sp1 activates all GC-rich sites. As a result, these Sp/KLF transcriptional repressors provide a novel mechanism for silencing a large number of genes that are already known to be activated by Sp1, particularly in response to TGFbeta.
###end p 13
###begin p 14
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 7 10 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 61 63 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 262 265 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 402 405 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 409 412 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 688 691 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 695 698 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
TGFbetaRII has been previously shown to be activated by Sp1 (14). However, since these elegant studies were done, 24 Sp/KLF transcription factors have been discovered with some members acting as activators while others as repressors via the same type of GC-rich cis regulatory sequences used by Sp1. Thus, some Sp/KLF transcription factors are excellent candidates that may play a role in silencing of TGFbetaRII. Indeed, fortunately, in the current study, we describe, for the first time, the functional characterization of KLF14 as a novel non-Smad regulatory protein of the TGFbeta pathway. Our results outline a novel, biochemically significant role for KLF14 in the silencing of the TGFbetaRII via Sp/KLF sites. This pathway provides a well characterized example of how Sp/KLF proteins are emerging as important non-Smad proteins that can directly regulate TGFbeta signaling by regulating the expression of key molecules from this pathway.
###end p 14
###begin title 15
EXPERIMENTAL PROCEDURES
###end title 15
###begin p 16
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture</italic>
###xml 394 395 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Cell Culture-Tissue culture reagents were purchased from commercial sources (Invitrogen). The human pancreatic epithelial cancer cell lines, PANC-1, ASPC-1, Capan-1, Capan-2, BxPC-3, L3.6, MiaPaCa-2, and CFPAC-1, were obtained from American Type Culture Collection and maintained according to the supplier's suggestions. All cells were grown at 37 degreesC in a humidified incubator under 5% CO2.
###end p 16
###begin p 17
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmid Construction</italic>
###xml 78 114 78 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF4, KLF5, KLF7, KLF9, KLF11, KLF14</italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF15</italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 304 307 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 584 587 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 591 594 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
Plasmid Construction-Standard molecular biology techniques were used to clone KLF4, KLF5, KLF7, KLF9, KLF11, KLF14, and KLF15 into the pcDNA3.1/His (Invitrogen) and pCMVtag2 (Stratagene) vectors for expression as His-tagged or FLAG-tagged proteins, respectively, as well as the truncated (263 bp) TGFbetaRII promoter into the pGL3-Lux vector (Promega). The p3TP-Lux reporter plasmid containing TGFbeta-responsive elements was kindly provided by Dr. Anita Roberts (National Institutes of Health) as a positive control for TGFbeta1 stimulation experiments (data not shown). Full-length TGFbetaRII reporter was kindly provided by Dr. David Danielpour (Case Western).
###end p 17
###begin p 18
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Semi-quantitative RT-PCR</italic>
###xml 621 626 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 652 653 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 669 672 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B2M</italic>
###xml 690 691 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 701 706 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUBB2</italic>
###xml 766 771 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
###xml 595 600 <span type="species:ncbi:9606">human</span>
Semi-quantitative RT-PCR-Total RNA was extracted from cells according to the manufacturer's instructions using an RNeasy Kit (Qiagen), and 5 mug was used for cDNA synthesis using oligo(dT) primer using the SuperScripttrade mark III First-Strand Synthesis System for RT-PCR (Invitrogen) per the manufacturer's protocol. RT-PCR was performed using LA TaqDNA Polymerase with a GC Buffers kit (Takara) per the manufacturer protocols. Semiquantitative RT-PCR analysis was performed with the primer sets provided in supplemental Table S1. Each experiment was done in triplicate. Amplification of four human housekeeping genes, GAPDH (Unigene Hs.544577), beta2-microglobulin (B2M, Hs.709313), beta2-Tubulin (TUBB2, Hs.300701), and hypoxanthine phosphoribosyltransferase 1 (HPRT1, Hs.412707) was used for all samples as an internal control. Densitometric values were obtained and normalized to the average of the housekeeping cDNAs for each individual sample using Scion Image Beta 4.02 software (Scion Corp.).
###end p 18
###begin p 19
###xml 52 55 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 281 285 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 884 888 866 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACTB</italic>
To represent the TGFbeta inducibility of individual KLF transcripts, each TGFbeta-treated sample was compared with an untreated control that was originally plated and ultimately collected at the same time to minimize compounding factors, which can often influence gene expression (i.e. cell cycle stage, cell density, potential unknown paracrine, and/or autocrine stimuli). At each time point, values were determined by first normalizing the TGFbeta-treated sample (T, treated) to the average of the four aforementioned housekeeping genes in the same sample (TC, treated housekeeping gene control). This resultant value was divided by the corresponding untreated sample (UT, untreated) normalized in the same manner (UTC, untreated housekeeping gene control), to express the fold of TGFbeta induction ([T/TC]/[UT/UTC] = fold TGFbeta-induction). Another housekeeping gene, beta-actin (ACTB, Hs.520640), was not used in our analyses, because it showed significant differences with TGFbeta treatment over control values (data not shown).
###end p 19
###begin p 20
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blot</italic>
Western Blot-Total protein extracts were prepared by lysing cells in radioimmune precipitation assay buffer supplemented with Complete protease inhibitor mixture (Roche Applied Science). Cellular lysates were subjected to 10% SDS-PAGE and then separated proteins are transferred to polyvinylidene difluoride membranes (Millipore). Membranes were incubated overnight at 4 degreesC in blocking solution (Tris-buffered saline solution containing 5% nonfat dried milk and 0.1% Tween 20). Subsequently, membranes were incubated with specified primary antibodies overnight at 4 degreesC. Immune complexes were visualized by enhanced chemiluminescence (Pierce) and exposed to x-ray film. An antibody against beta2-actin (Sigma) was used as loading control.
###end p 20
###begin p 21
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Transcriptional Reporter Assays</italic>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Transcriptional Reporter Assays-Cells were transfected with specified reporter constructs along with expression constructs and/or empty vector using electroporation (2 x 106 cells/0.4-cm microcuvette, 360 V, and 10 ms) and subsequently serum-starved overnight. Transfection was performed with equimolar concentrations of DNA, and expression was quantified with Western blotting directed against epitope-tagged proteins as described. Cells were stimulated with TGFbeta1 (R&D Systems) as specified and assayed at various specified time points. At 24 or 48 h after transfection and treatment as noted, cells were lysed, and luciferase measurements were performed using a 20/20 luminometer (Turner Designs) according to manufacturer's suggestions (Promega). Data were normalized as relative light units and normalized to the protein concentration as the mean +/- S.D. All experiments were performed in triplicate at least three independent times.
###end p 21
###begin p 22
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoprecipitation</italic>
###xml 149 150 149 150 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 180 181 180 181 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 204 205 204 205 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Immunoprecipitation-Cells were transfected with FLAG-tagged constructs. At 24 h post-transfection, cells were washed and lysed in lysis buffer (150 mm NaCl, 0.5% Nonidet P-40, 50 mm Tris-HCl, pH 7.5, 20 mm MgCl2) supplemented with Complete protease inhibitor tablets (Roche Applied Science) for 30 min at 4 degreesC. Immunoprecipitations were performed using anti-FLAG M2 agarose-conjugated antibodies (Sigma) for 2 h at 4 degreesC. To detect interaction with endogenous co-repressors, immunocomplexes were collected by centrifugation, washed with lysis buffer, and analyzed by Western blot as described above using anti-mSin3a and HDAC2 antibodies (Santa Cruz Biotechnology).
###end p 22
###begin p 23
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chromatin Immunoprecipitation</italic>
###xml 261 264 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
Chromatin Immunoprecipitation-ChIP assays were performed using the EZ-ChIP kit. The following primer set for the 263-bp TGFbetaRII promoter was used for PCR: 5'-GCA GAT GTT CTG ATC TAC TA-3' (forward); 5'-AGC TGG GCA GGA CCT CTC TC-3' (reverse) using TaKaRa LA Taq according to the manufacturer's protocol (Mirus).
###end p 23
###begin p 24
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Site-directed Mutagenesis</italic>
###xml 202 206 <span type="species:ncbi:162683">Mayo</span>
Site-directed Mutagenesis-Site-directed mutagenesis was performed with QuikChange(R) II site-directed mutagenesis kits per the manufacturer's protocol (Stratagene). All constructs were sequenced by the Mayo Clinic Molecular Biology Core Facility.
###end p 24
###begin p 25
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST Fusion</italic>
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 305 306 305 306 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 317 318 317 318 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
GST Fusion-The KLF14 cDNA fragment encoding amino acids 191-323 corresponding to the DNA-binding zinc finger region was cloned into the GST fusion vector pGEX 5X-1 (Amersham Biosciences) using standard techniques. GST fusion protein expression was induced in BL21 cells (Stratagene) by the addition of 1 mm isopropyl-d-thiogalactopyranoside and incubation for 2 h. Cells were lysed and subsequently purified by using glutathione-Sepharose 4B affinity chromatography as previously described (15).
###end p 25
###begin p 26
###xml 0 27 0 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Electromobility Shift Assay</italic>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 174 176 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 254 255 250 251 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 279 280 275 276 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 285 286 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 292 293 288 289 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 465 466 455 456 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 475 476 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 492 493 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 647 648 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 688 689 677 678 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 710 711 699 700 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 721 722 710 711 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 727 728 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 735 736 723 724 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 741 742 729 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 813 814 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 859 861 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 766 772 <span type="species:ncbi:9913">bovine</span>
###xml 1076 1082 <span type="species:ncbi:9986">rabbit</span>
Electromobility Shift Assay-Gel shift assays were performed as previously described (16). Briefly, 1.75 pmol of double-stranded oligonucleotides were end-labeled with [gamma-32P]ATP using 10 units of T4 polynucleotide kinase and appropriate buffer (700 mm Tris-HCl, pH 7.6, 100 mm MgCl2, 50 mm dithiothreitol) according to the manufacturer's instructions (Promega). The reaction was incubated at 37 degreesC for 10 min and halted with addition of TE plus EDTA (0.5 m EDTA, 1 m Tris, pH 8.0, H2O). Protein lysates included 0.5 mug of purified GST-KLF14/ZF fusion protein and in some experiments rhSP1 (Promega) at the indicated dilutions. A 5x ZnCl2 buffer was used in this reaction (100 mm Hepes, pH 7.5, 250 mm KCl, 25 mm MgCl2, 50 mum ZnCl2, 30% glycerol, 1 mg/ml bovine serum albumin, 250 mug/ml poly(dI-dC), H2O) for 10 min at room temperature. The gamma-32P-labeled oligonucleotides were added for 20 min. In some cases, an excess of cold probe, at the indicated dilutions, was added concomitant with the addition of radiolabeled probe in addition to anti-Sp1 polyclonal rabbit antibody purchased from commercial sources (Millipore). The mixtures were electrophoresed in a 4% nondenaturing polyacrylamide gel in a Hoeffer midi-gel using 0.5x Tris borate-EDTA for approximately4 h at 160 V. Gels were then transferred to blotting paper (Whatman 3MM), covered in plastic wrap, and vacuum dried for 1.5 h at 65 degreesC. Dried gels were then analyzed using a Storm Scanner 860 PhosphorImager (Amersham Biosciences). Sp1 consensus and Sp1 mutant double-stranded oligonucleotides were obtained from commercial sources (Santa Cruz Biotechnology) with the following sequences: Sp1 consensus, 5'-ATT CGA TCG GGG CGG GGC GAG C-3' (forward); 5'-GCT CGC CCC GCC CCG ATC GAA T-3' (reverse) and Sp1 mutant, 5'-ATT CGA TCG GTT CGG GGC GAG C-3' (forward); 5'-GCT CGC CCC GAA CCG ATC GAA T-3' (reverse).
###end p 26
###begin p 27
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 37 40 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 178 181 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 185 188 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 590 596 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, TGF</italic>
###xml 600 603 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 656 663 639 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">diagram</italic>
###xml 700 703 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 707 710 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 9 771 9 751 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><italic>A</italic>, repression of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter occurs after 24 h of TGF&#946; stimulation in Panc1 cells. Panc1 cells were transfected with a full-length and a truncated 263-bp <italic>TGF</italic>&#946;<italic>RII</italic> promoter luciferase reporter and then stimulated with TGF&#946;1 after overnight serum starvation. Luciferase levels were obtained at specified time points after treatment and compared with untreated controls. Values were normalized to lysate protein concentrations and relative to untreated controls. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment. <italic>B, TGF</italic>&#946;<italic>RII</italic> promoter has five putative &#8220;Sp1&#8221; binding sites. The <italic>diagram</italic> represents a schematic of the human <italic>TGF</italic>&#946;<italic>RII</italic> proximal promoter containing five GC-rich Sp1-like elements.</p>
###xml 9 771 9 751 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28"><italic>A</italic>, repression of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter occurs after 24 h of TGF&#946; stimulation in Panc1 cells. Panc1 cells were transfected with a full-length and a truncated 263-bp <italic>TGF</italic>&#946;<italic>RII</italic> promoter luciferase reporter and then stimulated with TGF&#946;1 after overnight serum starvation. Luciferase levels were obtained at specified time points after treatment and compared with untreated controls. Values were normalized to lysate protein concentrations and relative to untreated controls. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment. <italic>B, TGF</italic>&#946;<italic>RII</italic> promoter has five putative &#8220;Sp1&#8221; binding sites. The <italic>diagram</italic> represents a schematic of the human <italic>TGF</italic>&#946;<italic>RII</italic> proximal promoter containing five GC-rich Sp1-like elements.</p></caption>
###xml 771 771 751 751 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890001"/>
###xml 0 771 0 751 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="28"><italic>A</italic>, repression of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter occurs after 24 h of TGF&#946; stimulation in Panc1 cells. Panc1 cells were transfected with a full-length and a truncated 263-bp <italic>TGF</italic>&#946;<italic>RII</italic> promoter luciferase reporter and then stimulated with TGF&#946;1 after overnight serum starvation. Luciferase levels were obtained at specified time points after treatment and compared with untreated controls. Values were normalized to lysate protein concentrations and relative to untreated controls. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment. <italic>B, TGF</italic>&#946;<italic>RII</italic> promoter has five putative &#8220;Sp1&#8221; binding sites. The <italic>diagram</italic> represents a schematic of the human <italic>TGF</italic>&#946;<italic>RII</italic> proximal promoter containing five GC-rich Sp1-like elements.</p></caption><graphic xlink:href="zbc0110966890001"/></fig>
###xml 694 699 <span type="species:ncbi:9606">human</span>
FIGURE 1.A, repression of the TGFbetaRII promoter occurs after 24 h of TGFbeta stimulation in Panc1 cells. Panc1 cells were transfected with a full-length and a truncated 263-bp TGFbetaRII promoter luciferase reporter and then stimulated with TGFbeta1 after overnight serum starvation. Luciferase levels were obtained at specified time points after treatment and compared with untreated controls. Values were normalized to lysate protein concentrations and relative to untreated controls. Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment. B, TGFbetaRII promoter has five putative "Sp1" binding sites. The diagram represents a schematic of the human TGFbetaRII proximal promoter containing five GC-rich Sp1-like elements.
###end p 27
###begin p 28
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 28 31 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 169 172 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 176 179 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 581 587 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, TGF</italic>
###xml 591 594 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 647 654 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">diagram</italic>
###xml 691 694 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 698 701 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 685 690 <span type="species:ncbi:9606">human</span>
A, repression of the TGFbetaRII promoter occurs after 24 h of TGFbeta stimulation in Panc1 cells. Panc1 cells were transfected with a full-length and a truncated 263-bp TGFbetaRII promoter luciferase reporter and then stimulated with TGFbeta1 after overnight serum starvation. Luciferase levels were obtained at specified time points after treatment and compared with untreated controls. Values were normalized to lysate protein concentrations and relative to untreated controls. Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment. B, TGFbetaRII promoter has five putative "Sp1" binding sites. The diagram represents a schematic of the human TGFbetaRII proximal promoter containing five GC-rich Sp1-like elements.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 0 85 0 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A Yet Undefined Sp/KLF Repressor Protein Plays a Role in Silencing of the Type II TGF</italic>
###xml 89 107 86 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-receptor Promoter</italic>
###xml 162 165 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 169 172 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 276 278 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 280 282 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 370 372 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 373 375 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 762 765 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 769 772 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 883 886 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 890 893 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1060 1063 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1067 1070 1043 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1197 1199 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1310 1313 1280 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1317 1320 1284 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1380 1381 1347 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1374 1381 1341 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1437 1440 1404 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1444 1447 1408 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1529 1531 1493 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1621 1622 1585 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1615 1622 1579 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1839 1840 1800 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1833 1840 1794 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1864 1868 1825 1829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">#1&#8211;4</italic>
###xml 1932 1934 1893 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">#5</italic>
###xml 1970 1972 1931 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1974 1976 1935 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
A Yet Undefined Sp/KLF Repressor Protein Plays a Role in Silencing of the Type II TGFbeta-receptor Promoter-Previous studies have described the regulation of the TGFbetaRII by TGFbeta ligands, primarily showing a bimodal response consisting of an Sp1-dependent up-regulation (14, 17) and a subsequent down-regulation of receptor transcript levels upon this stimulation (18-20). Interestingly, although the activation of TGFbetaRII promoter, in particular by Sp1, has received precise attention, how this receptor is repressed remains poorly understood. Consequently, the major goal of the current study has been to characterize the role of a specific family of non-Smad proteins (Sp/KLF transcription factors), which may functionally explain the down-regulation TGFbetaRII through GC-rich Sp1-like sequences. Our studies began with examination of the transcriptional activity of the TGFbetaRII gene promoter in PANC1 epithelial cells, a widely used model for studying TGFbeta signaling. We have performed an initial series of reporter assays using full-length TGFbetaRII and the previously described, TGFbeta-sensitive, 263-bp core promoter, which is located 5' of the transcriptional start site (14). Treatment of PANC1 cells with exogenous TGFbeta1 leads to a marked reduction in activity of the full-length TGFbetaRII reporter when compared with untreated control cells (Fig. 1A). This silencing effect is recapitulated in the 263-bp TGFbetaRII core promoter, suggesting that both the previously described activation pathway (14) and the negative transcriptional regulatory mechanism characterized further here (Fig. 1A), are operational at this core promoter level. Using bioinformatics analyses (TRANSFAC Public), we have identified five putative Sp/KLF binding sites within this TGFbeta-sensitive, 263-bp core promoter region (Fig. 1B). Four of these sites (#1-4) have been previously identified, although an additional site (#5) has not been previously reported (14, 21). Some of these previously identified sites have been shown to be activated by Sp1. However, whether novel Sp/KLF silencer proteins can also bind to this sequence to reverse the activation by Sp1 remained unknown. Therefore, this analysis has led us to the hypothesis that a yet undefined Sp/KLF repressor protein plays a role in the silencing of this promoter.
###end p 30
###begin p 31
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Novel TGF</italic>
###xml 13 107 10 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-inducible Non-Smad, Sp/KLF Proteins Are Identified as Candidate Regulators of the Type II TGF</italic>
###xml 111 120 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-receptor</italic>
###xml 386 389 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 393 396 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 551 554 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 558 561 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 632 634 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 668 669 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 662 669 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 692 698 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 856 862 838 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 975 978 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 982 985 958 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1127 1130 1103 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1134 1137 1107 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1391 1394 1364 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1398 1401 1368 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1675 1678 1642 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1682 1685 1646 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 445 450 <span type="species:ncbi:9606">human</span>
Novel TGFbeta-inducible Non-Smad, Sp/KLF Proteins Are Identified as Candidate Regulators of the Type II TGFbeta-receptor- To test our hypothesis, we have developed a four-tier screening approach. This approach includes first, testing which of the 24 known Sp/KLF proteins are expressed in TGFbeta-sensitive epithelial cells and, thus, can be considered initial candidates to target the TGFbetaRII promoter. Our experimental cell model, PANC1, a human epithelial cell line, is an optimal model for our studies, because they have adequate expression of TGFbetaRII mRNA and display growth inhibition to exogenous TGFbeta1 stimulation (22). In addition, as shown in Fig. 2A, each of the 24 known Sp/KLF transcription factors are consistently expressed in these cells, which made it ideal for performing a comprehensive screen. Second, we determine whether any Sp/KLF genes are TGFbeta-inducible with a kinetic that is consistent with playing a role in the down-regulation of the TGFbetaRII. Third, by utilizing transfection studies combined with reporter assays, we test the potential of distinct members of this family to repress TGFbetaRII promoter activity and then, by electromobility shift assays, determine which sites on the promoter are utilized by our candidate KLF protein. Finally, we examine whether the repressor that is isolated according to these criteria binds to the endogenous TGFbetaRII gene and can remodel chromatin on this target, suggesting the bona fide target status of the candidate KLF protein. Thus, by applying this comprehensive screening, our study has been robust in evaluating the KLF protein family in the TGFbeta response and regulation of the TGFbetaRII.
###end p 31
###begin p 32
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 159 162 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 345 351 339 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 528 529 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 522 529 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 631 634 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 703 709 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 901 904 880 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 908 911 884 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 928 929 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 922 929 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1011 1016 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF11</italic>
###xml 1046 1048 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1050 1052 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1119 1122 1092 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 1156 1177 1129 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF4, -5, -7, -9, -14</italic>
###xml 1183 1186 1156 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-15</italic>
###xml 1317 1320 1290 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1324 1327 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
The genomic axiom that functionally related genes follow a similar pattern of expression suggested that, hypothetically, the protein that represses the TGFbetaRII may be expressed in a similar manner after TGFbeta treatment, in particular, during the repression response to this cytokine. Consequently, we have evaluated which, if any, of these Sp/KLF members are inducible by TGFbeta1 treatment. Thus, using RNA from PANC1 cells either untreated or treated with TGFbeta1, we have performed RT-PCR at various time points (Fig. 2B). As a positive control for TGFbeta-mediated transcriptional induction, we monitor the expression of p21, a known TGFbeta-inducible gene within the pathway. Of the 24 known Sp/KLF transcription factors, we have identified 7 that were markedly induced with exogenous TGFbeta1 treatment, suggesting that these could be potential candidate transcriptional repressors of the TGFbetaRII promoter (Fig. 2B). These results are not only consistent with our previous work, which identified KLF11 as a TGFbeta-inducible gene (16, 23), but, more importantly, it characterizes previously unidentified KLF targets for this cascade, namely KLF4, -5, -7, -9, -14, and -15. Thus, based upon their expression patterns, these seven genes are good candidates to further investigate their regulation of the TGFbetaRII promoter.
###end p 32
###begin p 33
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 247 248 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 293 296 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 427 430 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 496 499 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 675 678 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 781 798 766 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH, B2M, TUBB2</italic>
###xml 804 809 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
###xml 862 863 847 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1100 1117 1079 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH, B2M, TUBB2</italic>
###xml 1123 1128 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
###xml 9 1315 9 1291 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><italic>A</italic>, eight pancreatic cancer cell lines were screened by RT-PCR for expression of 24 members of the <italic>Sp/KLF</italic> family of transcription factors. The figure shows that all 24 <italic>Sp/KLF</italic> members are expressed in the TGF&#946;-sensitive Panc1 cell line. <italic>B</italic>, TGF&#946;1 induces the expression of several <italic>KLF</italic> family members. Panc1 cells were serum-starved overnight, treated with 10 ng/ml TGF&#946;1, and screened for the expression of each <italic>KLF</italic> gene by semi-quantitative RT-PCR. The expression levels for each <italic>KLF</italic> gene from TGF&#946;1-treated samples were compared with untreated controls and normalized to housekeeping genes as described under &#8220;Material and Methods.&#8221; The expression of the <italic>p21</italic> gene was used as a positive control for TGF&#946;1 treatment. Four different housekeeping genes, namely <italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>, were used as internal standards for normalization. <italic>C</italic>, quantification of TGF&#946; induction of transcript levels over time. At each time point, values were determined by first normalizing the densitometric measurement of the TGF&#946;-treated sample to the average of four housekeeping genes (<italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>) in the same sample. This resulting value was divided by the corresponding value of the untreated sample normalized in the same manner in order to express the -fold of TGF&#946; induction.</p>
###xml 9 1315 9 1291 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><italic>A</italic>, eight pancreatic cancer cell lines were screened by RT-PCR for expression of 24 members of the <italic>Sp/KLF</italic> family of transcription factors. The figure shows that all 24 <italic>Sp/KLF</italic> members are expressed in the TGF&#946;-sensitive Panc1 cell line. <italic>B</italic>, TGF&#946;1 induces the expression of several <italic>KLF</italic> family members. Panc1 cells were serum-starved overnight, treated with 10 ng/ml TGF&#946;1, and screened for the expression of each <italic>KLF</italic> gene by semi-quantitative RT-PCR. The expression levels for each <italic>KLF</italic> gene from TGF&#946;1-treated samples were compared with untreated controls and normalized to housekeeping genes as described under &#8220;Material and Methods.&#8221; The expression of the <italic>p21</italic> gene was used as a positive control for TGF&#946;1 treatment. Four different housekeeping genes, namely <italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>, were used as internal standards for normalization. <italic>C</italic>, quantification of TGF&#946; induction of transcript levels over time. At each time point, values were determined by first normalizing the densitometric measurement of the TGF&#946;-treated sample to the average of four housekeeping genes (<italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>) in the same sample. This resulting value was divided by the corresponding value of the untreated sample normalized in the same manner in order to express the -fold of TGF&#946; induction.</p></caption>
###xml 1315 1315 1291 1291 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890002"/>
###xml 0 1315 0 1291 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="34"><italic>A</italic>, eight pancreatic cancer cell lines were screened by RT-PCR for expression of 24 members of the <italic>Sp/KLF</italic> family of transcription factors. The figure shows that all 24 <italic>Sp/KLF</italic> members are expressed in the TGF&#946;-sensitive Panc1 cell line. <italic>B</italic>, TGF&#946;1 induces the expression of several <italic>KLF</italic> family members. Panc1 cells were serum-starved overnight, treated with 10 ng/ml TGF&#946;1, and screened for the expression of each <italic>KLF</italic> gene by semi-quantitative RT-PCR. The expression levels for each <italic>KLF</italic> gene from TGF&#946;1-treated samples were compared with untreated controls and normalized to housekeeping genes as described under &#8220;Material and Methods.&#8221; The expression of the <italic>p21</italic> gene was used as a positive control for TGF&#946;1 treatment. Four different housekeeping genes, namely <italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>, were used as internal standards for normalization. <italic>C</italic>, quantification of TGF&#946; induction of transcript levels over time. At each time point, values were determined by first normalizing the densitometric measurement of the TGF&#946;-treated sample to the average of four housekeeping genes (<italic>GAPDH, B2M, TUBB2</italic>, and <italic>HPRT1</italic>) in the same sample. This resulting value was divided by the corresponding value of the untreated sample normalized in the same manner in order to express the -fold of TGF&#946; induction.</p></caption><graphic xlink:href="zbc0110966890002"/></fig>
FIGURE 2.A, eight pancreatic cancer cell lines were screened by RT-PCR for expression of 24 members of the Sp/KLF family of transcription factors. The figure shows that all 24 Sp/KLF members are expressed in the TGFbeta-sensitive Panc1 cell line. B, TGFbeta1 induces the expression of several KLF family members. Panc1 cells were serum-starved overnight, treated with 10 ng/ml TGFbeta1, and screened for the expression of each KLF gene by semi-quantitative RT-PCR. The expression levels for each KLF gene from TGFbeta1-treated samples were compared with untreated controls and normalized to housekeeping genes as described under "Material and Methods." The expression of the p21 gene was used as a positive control for TGFbeta1 treatment. Four different housekeeping genes, namely GAPDH, B2M, TUBB2, and HPRT1, were used as internal standards for normalization. C, quantification of TGFbeta induction of transcript levels over time. At each time point, values were determined by first normalizing the densitometric measurement of the TGFbeta-treated sample to the average of four housekeeping genes (GAPDH, B2M, TUBB2, and HPRT1) in the same sample. This resulting value was divided by the corresponding value of the untreated sample normalized in the same manner in order to express the -fold of TGFbeta induction.
###end p 33
###begin p 34
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 238 239 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 284 287 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 418 421 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 487 490 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 666 669 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 772 789 757 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH, B2M, TUBB2</italic>
###xml 795 800 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
###xml 853 854 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1091 1108 1070 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH, B2M, TUBB2</italic>
###xml 1114 1119 1093 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
A, eight pancreatic cancer cell lines were screened by RT-PCR for expression of 24 members of the Sp/KLF family of transcription factors. The figure shows that all 24 Sp/KLF members are expressed in the TGFbeta-sensitive Panc1 cell line. B, TGFbeta1 induces the expression of several KLF family members. Panc1 cells were serum-starved overnight, treated with 10 ng/ml TGFbeta1, and screened for the expression of each KLF gene by semi-quantitative RT-PCR. The expression levels for each KLF gene from TGFbeta1-treated samples were compared with untreated controls and normalized to housekeeping genes as described under "Material and Methods." The expression of the p21 gene was used as a positive control for TGFbeta1 treatment. Four different housekeeping genes, namely GAPDH, B2M, TUBB2, and HPRT1, were used as internal standards for normalization. C, quantification of TGFbeta induction of transcript levels over time. At each time point, values were determined by first normalizing the densitometric measurement of the TGFbeta-treated sample to the average of four housekeeping genes (GAPDH, B2M, TUBB2, and HPRT1) in the same sample. This resulting value was divided by the corresponding value of the untreated sample normalized in the same manner in order to express the -fold of TGFbeta induction.
###end p 34
###begin p 35
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 136 139 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 159 160 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 359 362 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 366 369 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 389 390 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 619 622 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 626 629 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 9 1065 9 1048 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><italic>A</italic>, Panc1 cells were transfected with KLF(FLAG/His) epitope-tagged expression constructs or control empty vector to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>B</italic>, Panc1 cells were transfected with indicated KLF(FLAG/His) epitope-tagged expression constructs or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>C</italic>, Panc1 cells were transfected with various concentrations of epitope-tagged KLF14(FLAG) expression construct or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to observe the effect on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western controls (FLAG/His) were shown for epitope-tagged KLF expression in all experiments. Expression of FLAG-tagged KLF4, KLF7, KLF14, and KLF15 was confirmed by an anti-FLAG antibody (Sigma), whereas expression of His-tagged KLF5, KLF9, and KLF11 was verified by the OMNI D8 antibody (Santa Cruz Biotechnology). Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p>
###xml 9 1065 9 1048 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><italic>A</italic>, Panc1 cells were transfected with KLF(FLAG/His) epitope-tagged expression constructs or control empty vector to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>B</italic>, Panc1 cells were transfected with indicated KLF(FLAG/His) epitope-tagged expression constructs or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>C</italic>, Panc1 cells were transfected with various concentrations of epitope-tagged KLF14(FLAG) expression construct or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to observe the effect on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western controls (FLAG/His) were shown for epitope-tagged KLF expression in all experiments. Expression of FLAG-tagged KLF4, KLF7, KLF14, and KLF15 was confirmed by an anti-FLAG antibody (Sigma), whereas expression of His-tagged KLF5, KLF9, and KLF11 was verified by the OMNI D8 antibody (Santa Cruz Biotechnology). Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p></caption>
###xml 1065 1065 1048 1048 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890003"/>
###xml 0 1065 0 1048 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="36"><italic>A</italic>, Panc1 cells were transfected with KLF(FLAG/His) epitope-tagged expression constructs or control empty vector to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>B</italic>, Panc1 cells were transfected with indicated KLF(FLAG/His) epitope-tagged expression constructs or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to test <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. <italic>C</italic>, Panc1 cells were transfected with various concentrations of epitope-tagged KLF14(FLAG) expression construct or control vector and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation to observe the effect on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western controls (FLAG/His) were shown for epitope-tagged KLF expression in all experiments. Expression of FLAG-tagged KLF4, KLF7, KLF14, and KLF15 was confirmed by an anti-FLAG antibody (Sigma), whereas expression of His-tagged KLF5, KLF9, and KLF11 was verified by the OMNI D8 antibody (Santa Cruz Biotechnology). Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p></caption><graphic xlink:href="zbc0110966890003"/></fig>
FIGURE 3.A, Panc1 cells were transfected with KLF(FLAG/His) epitope-tagged expression constructs or control empty vector to test TGFbetaRII promoter activity. B, Panc1 cells were transfected with indicated KLF(FLAG/His) epitope-tagged expression constructs or control vector and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation to test TGFbetaRII promoter activity. C, Panc1 cells were transfected with various concentrations of epitope-tagged KLF14(FLAG) expression construct or control vector and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation to observe the effect on TGFbetaRII promoter activity. Western controls (FLAG/His) were shown for epitope-tagged KLF expression in all experiments. Expression of FLAG-tagged KLF4, KLF7, KLF14, and KLF15 was confirmed by an anti-FLAG antibody (Sigma), whereas expression of His-tagged KLF5, KLF9, and KLF11 was verified by the OMNI D8 antibody (Santa Cruz Biotechnology). Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment.
###end p 35
###begin p 36
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 127 130 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 150 151 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 350 353 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 357 360 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 380 381 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 610 613 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 617 620 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
A, Panc1 cells were transfected with KLF(FLAG/His) epitope-tagged expression constructs or control empty vector to test TGFbetaRII promoter activity. B, Panc1 cells were transfected with indicated KLF(FLAG/His) epitope-tagged expression constructs or control vector and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation to test TGFbetaRII promoter activity. C, Panc1 cells were transfected with various concentrations of epitope-tagged KLF14(FLAG) expression construct or control vector and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation to observe the effect on TGFbetaRII promoter activity. Western controls (FLAG/His) were shown for epitope-tagged KLF expression in all experiments. Expression of FLAG-tagged KLF4, KLF7, KLF14, and KLF15 was confirmed by an anti-FLAG antibody (Sigma), whereas expression of His-tagged KLF5, KLF9, and KLF11 was verified by the OMNI D8 antibody (Santa Cruz Biotechnology). Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment.
###end p 36
###begin p 37
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 92 95 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 162 165 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 169 172 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 259 262 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF</italic>
###xml 334 337 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 341 344 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 406 407 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 400 407 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 430 433 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 437 440 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 649 652 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 656 659 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 719 722 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 726 729 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 980 983 953 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 987 990 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1063 1064 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1057 1064 1027 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1369 1374 1336 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 1490 1491 1454 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1484 1491 1448 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1583 1586 1547 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1590 1593 1551 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
Subsequently, we have tested the transcriptional activity of these candidates on the TGFbetaRII promoter using reporter assays by co-transfecting the 263-bp core TGFbetaRII promoter-luciferase construct with cDNAs encoding each of the seven TGFbeta-inducible KLF candidates. Out of these, five candidates induced a marked decrease in TGFbetaRII promoter activity, namely KLF4, -7, -11, -14, and -15 (Fig. 3A). KLF5 did not affect TGFbetaRII promoter activity above control levels, whereas KLF9 appeared to slightly activate this promoter, therefore these two proteins were not continued in subsequent experiments due to our objective of identifying TGFbetaRII repressors. To confirm whether this observed repression of TGFbetaRII promoter regulation is consistent with TGFbeta pathway activation, these five proteins were further tested in PANC1 cells treated with exogenous TGFbeta1 treatment. Interestingly, upon treatment, these KLF proteins were capable of further repressing TGFbetaRII promoter activity, with the largest repression achieved by KLF14 (Fig. 3B). These data also indicate that a second TGFbeta-dependent mechanism, directly (signal-induced KLF expression or post-translational modifications) or indirectly (induction of another transcription factor), cooperates with KLF proteins to additionally repress this gene. Upon increasing concentrations of KLF14 cDNA in transfection studies, we found a concentration-dependent repression of the core TGFbetaRII promoter (Fig. 3C). Together, these results strongly identify KLF14 as a good candidate to be a regulator of TGFbetaRII promoter activity and expression.
###end p 37
###begin p 38
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14, a Novel Non-Smad Protein, Regulates the Type II TGF</italic>
###xml 62 71 59 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-receptor</italic>
###xml 150 155 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BTEB5</italic>
###xml 244 245 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn7">5</xref>
###xml 383 385 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 575 578 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 582 585 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
KLF14, a Novel Non-Smad Protein, Regulates the Type II TGFbeta-receptor-The gene encoding KLF14 has been previously identified by our group and named BTEB5 due to its sequence similarities to members of this subfamily of KLF silencing proteins.5 Although, recently, genetic studies have reported the genomic structure, intronless nature, and potential imprinted status of this gene (24), a functional characterization of this protein at the cellular and biochemical level has never been performed. Because our data indicate that KLF14 appears to be a potent regulator of the TGFbetaRII in promoter assays combined with this existing gap in knowledge on this KLF family member and its targets, the choice to further investigate the role of this particular KLF in TGFbetaRII regulation would significantly expand the current knowledge on the functional properties of members of this family.
###end p 38
###begin p 39
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 239 242 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 246 249 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 375 378 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 382 385 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 440 445 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 491 494 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 498 501 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 509 510 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 503 510 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 752 753 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 746 753 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 959 964 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 1033 1038 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 1092 1095 1056 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1099 1102 1060 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1196 1202 1154 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp/KLF</italic>
###xml 1293 1296 1248 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1300 1303 1252 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1324 1329 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 1451 1454 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1458 1461 1407 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1551 1554 1497 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 1556 1558 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1611 1614 1554 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 1703 1704 1646 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1709 1710 1652 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1695 1710 1638 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>C</italic> and <italic>D</italic></xref>
###xml 1740 1743 1683 1686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 1811 1812 1751 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1817 1818 1757 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1803 1818 1743 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>C</italic> and <italic>D</italic></xref>
###xml 1973 1976 1910 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1980 1983 1914 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
Noteworthy, we have validated these in vitro reporter results in vivo by assessing whether this protein has a regulatory effect on endogenous TGFbetaRII levels in PANC1 cells. Initial correlative experiments demonstrate that the levels of TGFbetaRII mRNA levels decrease at a time in which the amount of KLF14 increases (repression phase of the bimodal expression pattern of TGFbetaRII in response to TGFbeta), raising the possibility that KLF14 is induced to subsequently down-regulate the TGFbetaRII (Fig. 4A). To mechanistically support this correlation, we have performed RT-PCR on cells overexpressing KLF14 to determine TGFbetaRII levels in comparison to mock transfected cells in the presence or absence of exogenous TGFbeta1 stimulation (Fig. 4B). KLF14 overexpression alone is sufficient to decrease TGFbetaRII mRNA, interestingly to the same extent as TGFbeta1 stimulation alone. Furthermore, subsequent TGFbeta1 treatment in cells transfected with KLF14 leads to further down-regulation of TGFbetaRII transcripts. Because KLF14 is a TGFbeta-inducible gene, the further decrease in TGFbetaRII mRNA levels observed upon TGFbeta1 treatment likely results from the induction of endogenous Sp/KLF transcription factors by this cytokine. These results suggest that TGFbeta down-regulates TGFbetaRII transcripts through KLF14 expression with subsequent negative regulation of promoter activity. Next, we have tested whether the effect of KLF14 on TGFbetaRII expression interfered with TGFbeta-induced signals that target downstream genes, such as p21 (25). Indeed, as expected, TGFbeta1 treatment increases p21 promoter activity, as observed via reporter assays, as well as its mRNA levels (Fig. 4, C and D), whereas KLF14 reduces both p21 promoter activity and mRNA levels upon TGFbeta1 treatment (Fig. 4, C and D). These results suggest that KLF14 interferes with the activation of downstream TGFbetasignaling effects, at least in part, by its ability to repress the TGFbetaRII.
###end p 39
###begin p 40
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, TGF</italic>
###xml 19 22 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 27 32 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 155 158 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 162 165 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 171 176 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 186 191 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 197 202 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 273 274 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 302 305 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 309 312 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 609 610 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 720 723 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 905 906 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 934 937 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 9 1237 9 1217 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41"><italic>A, TGF</italic>&#946;<italic>RII</italic> and <italic>KLF14</italic> transcript levels were analyzed by determination of density, and relative transcript levels were represented by the ratio <italic>TGF</italic>&#946;<italic>RII</italic> cDNA/<italic>GAPDH</italic> cDNA and <italic>KLF14</italic> cDNA/<italic>GAPDH</italic> cDNA. Data were the mean &#177; S.D. from three independent experiments. <italic>B</italic>, KLF14 inhibits endogenous <italic>TGF</italic>&#946;<italic>RII</italic> transcript levels. Panc1 cells were transfected with KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was performed after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA. <italic>C</italic>, Panc1 cells were transfected with KLF14 FLAG epitope-tagged constructs or control empty vector along with a <italic>p21</italic> promoter reporter construct and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation. Western control for KLF14(FLAG) epitope-tagged protein expression is shown. <italic>D</italic>, KLF14 inhibits endogenous <italic>p21</italic> transcript levels. Panc1 cells were transfected with FLAG-KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was obtained after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA.</p>
###xml 9 1237 9 1217 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41"><italic>A, TGF</italic>&#946;<italic>RII</italic> and <italic>KLF14</italic> transcript levels were analyzed by determination of density, and relative transcript levels were represented by the ratio <italic>TGF</italic>&#946;<italic>RII</italic> cDNA/<italic>GAPDH</italic> cDNA and <italic>KLF14</italic> cDNA/<italic>GAPDH</italic> cDNA. Data were the mean &#177; S.D. from three independent experiments. <italic>B</italic>, KLF14 inhibits endogenous <italic>TGF</italic>&#946;<italic>RII</italic> transcript levels. Panc1 cells were transfected with KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was performed after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA. <italic>C</italic>, Panc1 cells were transfected with KLF14 FLAG epitope-tagged constructs or control empty vector along with a <italic>p21</italic> promoter reporter construct and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation. Western control for KLF14(FLAG) epitope-tagged protein expression is shown. <italic>D</italic>, KLF14 inhibits endogenous <italic>p21</italic> transcript levels. Panc1 cells were transfected with FLAG-KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was obtained after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA.</p></caption>
###xml 1237 1237 1217 1217 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890004"/>
###xml 0 1237 0 1217 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="41"><italic>A, TGF</italic>&#946;<italic>RII</italic> and <italic>KLF14</italic> transcript levels were analyzed by determination of density, and relative transcript levels were represented by the ratio <italic>TGF</italic>&#946;<italic>RII</italic> cDNA/<italic>GAPDH</italic> cDNA and <italic>KLF14</italic> cDNA/<italic>GAPDH</italic> cDNA. Data were the mean &#177; S.D. from three independent experiments. <italic>B</italic>, KLF14 inhibits endogenous <italic>TGF</italic>&#946;<italic>RII</italic> transcript levels. Panc1 cells were transfected with KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was performed after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA. <italic>C</italic>, Panc1 cells were transfected with KLF14 FLAG epitope-tagged constructs or control empty vector along with a <italic>p21</italic> promoter reporter construct and then stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation. Western control for KLF14(FLAG) epitope-tagged protein expression is shown. <italic>D</italic>, KLF14 inhibits endogenous <italic>p21</italic> transcript levels. Panc1 cells were transfected with FLAG-KLF14 or control empty vector and then stimulated with 10 ng/ml TGF&#946;1 for 24 h after overnight serum starvation. Densitometry was obtained after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA.</p></caption><graphic xlink:href="zbc0110966890004"/></fig>
FIGURE 4.A, TGFbetaRII and KLF14 transcript levels were analyzed by determination of density, and relative transcript levels were represented by the ratio TGFbetaRII cDNA/GAPDH cDNA and KLF14 cDNA/GAPDH cDNA. Data were the mean +/- S.D. from three independent experiments. B, KLF14 inhibits endogenous TGFbetaRII transcript levels. Panc1 cells were transfected with KLF14 or control empty vector and then stimulated with 10 ng/ml TGFbeta1 for 24 h after overnight serum starvation. Densitometry was performed after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA. C, Panc1 cells were transfected with KLF14 FLAG epitope-tagged constructs or control empty vector along with a p21 promoter reporter construct and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation. Western control for KLF14(FLAG) epitope-tagged protein expression is shown. D, KLF14 inhibits endogenous p21 transcript levels. Panc1 cells were transfected with FLAG-KLF14 or control empty vector and then stimulated with 10 ng/ml TGFbeta1 for 24 h after overnight serum starvation. Densitometry was obtained after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA.
###end p 40
###begin p 41
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, TGF</italic>
###xml 10 13 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 18 23 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 146 149 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 153 156 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 162 167 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 177 182 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 188 193 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 264 265 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 293 296 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 300 303 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 600 601 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 711 714 697 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 896 897 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 925 928 908 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
A, TGFbetaRII and KLF14 transcript levels were analyzed by determination of density, and relative transcript levels were represented by the ratio TGFbetaRII cDNA/GAPDH cDNA and KLF14 cDNA/GAPDH cDNA. Data were the mean +/- S.D. from three independent experiments. B, KLF14 inhibits endogenous TGFbetaRII transcript levels. Panc1 cells were transfected with KLF14 or control empty vector and then stimulated with 10 ng/ml TGFbeta1 for 24 h after overnight serum starvation. Densitometry was performed after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA. C, Panc1 cells were transfected with KLF14 FLAG epitope-tagged constructs or control empty vector along with a p21 promoter reporter construct and then stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation. Western control for KLF14(FLAG) epitope-tagged protein expression is shown. D, KLF14 inhibits endogenous p21 transcript levels. Panc1 cells were transfected with FLAG-KLF14 or control empty vector and then stimulated with 10 ng/ml TGFbeta1 for 24 h after overnight serum starvation. Densitometry was obtained after normalizing to the average of GAPDH, B2M, TUBB2, and HPRT1 levels and untreated control cDNA.
###end p 41
###begin p 42
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14 Represses the TGF</italic>
###xml 27 104 24 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII Promoter via Distinct Sp1-like GC-rich Sequences and Competition with Sp1</italic>
###xml 277 283 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP1A1</italic>
###xml 288 292 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLR</italic>
###xml 304 306 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 308 310 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 392 395 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 399 402 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 441 444 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp1</italic>
###xml 483 484 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 477 484 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 514 517 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp1</italic>
###xml 642 645 636 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 649 652 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 754 757 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 761 764 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
KLF14 Represses the TGFbetaRII Promoter via Distinct Sp1-like GC-rich Sequences and Competition with Sp1-Repressor KLF proteins, such as KLF14, have been previously shown to compete with the canonical Sp1 protein for overall transcriptional activity of a promoter, such as the CYP1A1 and LDLR promoters (26, 27). Therefore, herein we test the ability of KLF14 to repress transcription of the TGFbetaRII promoter in the presence of exogenous Sp1 expression. Indeed, as shown in Fig. 5A, the expression of exogenous Sp1 relieves the repression mediated by KLF14 in a dose-dependent manner. Due to the direct, Sp1-dependent up-regulation of the TGFbetaRII promoter as part of its bimodal response during activation, we dissect whether the repression of the TGFbetaRII promoter via KLF14 is also acting through a direct mechanism on the promoter rather than indirect due to KLF14 mediating a secondary effector.
###end p 42
###begin p 43
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 53 56 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 221 228 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 244 247 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 251 254 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 429 430 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 507 510 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 514 517 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 680 686 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 727 733 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 771 777 760 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 828 834 817 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 856 862 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 887 893 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 918 924 907 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 965 971 954 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
###xml 1013 1019 1002 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 9</italic>
###xml 1054 1061 1043 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 10</italic>
###xml 1104 1111 1093 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 11</italic>
###xml 1166 1180 1155 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open arrowhead</italic>
###xml 1193 1209 1182 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed arrowhead</italic>
###xml 1225 1230 1214 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blots</italic>
###xml 1277 1278 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1328 1331 1317 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1335 1338 1321 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1348 1355 1334 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1391 1394 1377 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1398 1401 1381 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 9 1703 9 1681 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><italic>A</italic>, KLF14 and Sp1 compete to regulate <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Panc1 cells were transfected with KLF14(FLAG) and Sp1(His) epitope-tagged expression constructs or control empty vector as indicated to evaluate <italic>in vivo</italic> competition on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western control (FLAG/His) is shown for epitope-tagged expression. Data are the mean &#177; S.D. from three independent experiments, each done in triplicate. <italic>B</italic>, KLF14 binds to four of the putative Sp1 sites and competes with Sp1 on the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Electromobility shift assay was performed using KLF14-ZF GST fusion proteins and radiolabeled oligonucleotides for each of the five putative Sp1 sites. <italic>Lane 1</italic>: control-Sp1 consensus oligonucleotide; <italic>lane 2</italic>: control-Sp1 mutant oligonucleotide; <italic>lane 3</italic>: Sp1 consensus oligonucleotide and rhSP1 protein; <italic>lane 4</italic>: WT oligonucleotide; <italic>lane 5</italic>: mut#1 oligonucleotide; <italic>lane 6</italic>: mut#2 oligonucleotide; <italic>lane 7</italic>: WT oligonucleotide and 25&#215; cold probe; <italic>lane 8</italic>: WT oligonucleotide and 100&#215; cold probe; <italic>lane 9</italic>: WT oligonucleotide and anti-GST; <italic>lane 10</italic>: WT oligonucleotide and 1&#215; rhSp1 protein; <italic>lane 11</italic>: WT oligonucleotide and 5&#215; rhSp1 protein. KLF14 band (<italic>open arrowhead</italic>). Sp1 band (<italic>closed arrowhead</italic>). The depicted <italic>blots</italic> are representative of triplicate experiments. <italic>C</italic>, KLF14 utilizes four Sp/KLF sites to repress the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with <italic>TGF</italic>&#946;<italic>RII</italic>-luciferase with mutated Sp1 sites as indicated and stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation, and transcriptional activity was measured and normalized to control empty vector. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p>
###xml 9 1703 9 1681 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><italic>A</italic>, KLF14 and Sp1 compete to regulate <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Panc1 cells were transfected with KLF14(FLAG) and Sp1(His) epitope-tagged expression constructs or control empty vector as indicated to evaluate <italic>in vivo</italic> competition on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western control (FLAG/His) is shown for epitope-tagged expression. Data are the mean &#177; S.D. from three independent experiments, each done in triplicate. <italic>B</italic>, KLF14 binds to four of the putative Sp1 sites and competes with Sp1 on the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Electromobility shift assay was performed using KLF14-ZF GST fusion proteins and radiolabeled oligonucleotides for each of the five putative Sp1 sites. <italic>Lane 1</italic>: control-Sp1 consensus oligonucleotide; <italic>lane 2</italic>: control-Sp1 mutant oligonucleotide; <italic>lane 3</italic>: Sp1 consensus oligonucleotide and rhSP1 protein; <italic>lane 4</italic>: WT oligonucleotide; <italic>lane 5</italic>: mut#1 oligonucleotide; <italic>lane 6</italic>: mut#2 oligonucleotide; <italic>lane 7</italic>: WT oligonucleotide and 25&#215; cold probe; <italic>lane 8</italic>: WT oligonucleotide and 100&#215; cold probe; <italic>lane 9</italic>: WT oligonucleotide and anti-GST; <italic>lane 10</italic>: WT oligonucleotide and 1&#215; rhSp1 protein; <italic>lane 11</italic>: WT oligonucleotide and 5&#215; rhSp1 protein. KLF14 band (<italic>open arrowhead</italic>). Sp1 band (<italic>closed arrowhead</italic>). The depicted <italic>blots</italic> are representative of triplicate experiments. <italic>C</italic>, KLF14 utilizes four Sp/KLF sites to repress the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with <italic>TGF</italic>&#946;<italic>RII</italic>-luciferase with mutated Sp1 sites as indicated and stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation, and transcriptional activity was measured and normalized to control empty vector. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p></caption>
###xml 1703 1703 1681 1681 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890005"/>
###xml 0 1703 0 1681 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="44"><italic>A</italic>, KLF14 and Sp1 compete to regulate <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Panc1 cells were transfected with KLF14(FLAG) and Sp1(His) epitope-tagged expression constructs or control empty vector as indicated to evaluate <italic>in vivo</italic> competition on <italic>TGF</italic>&#946;<italic>RII</italic> promoter activity. Western control (FLAG/His) is shown for epitope-tagged expression. Data are the mean &#177; S.D. from three independent experiments, each done in triplicate. <italic>B</italic>, KLF14 binds to four of the putative Sp1 sites and competes with Sp1 on the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Electromobility shift assay was performed using KLF14-ZF GST fusion proteins and radiolabeled oligonucleotides for each of the five putative Sp1 sites. <italic>Lane 1</italic>: control-Sp1 consensus oligonucleotide; <italic>lane 2</italic>: control-Sp1 mutant oligonucleotide; <italic>lane 3</italic>: Sp1 consensus oligonucleotide and rhSP1 protein; <italic>lane 4</italic>: WT oligonucleotide; <italic>lane 5</italic>: mut#1 oligonucleotide; <italic>lane 6</italic>: mut#2 oligonucleotide; <italic>lane 7</italic>: WT oligonucleotide and 25&#215; cold probe; <italic>lane 8</italic>: WT oligonucleotide and 100&#215; cold probe; <italic>lane 9</italic>: WT oligonucleotide and anti-GST; <italic>lane 10</italic>: WT oligonucleotide and 1&#215; rhSp1 protein; <italic>lane 11</italic>: WT oligonucleotide and 5&#215; rhSp1 protein. KLF14 band (<italic>open arrowhead</italic>). Sp1 band (<italic>closed arrowhead</italic>). The depicted <italic>blots</italic> are representative of triplicate experiments. <italic>C</italic>, KLF14 utilizes four Sp/KLF sites to repress the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with <italic>TGF</italic>&#946;<italic>RII</italic>-luciferase with mutated Sp1 sites as indicated and stimulated with 10 ng/ml TGF&#946;1 after overnight serum starvation, and transcriptional activity was measured and normalized to control empty vector. Data are the mean &#177; S.D. from three independent experiments, with triplicates for each experiment.</p></caption><graphic xlink:href="zbc0110966890005"/></fig>
FIGURE 5.A, KLF14 and Sp1 compete to regulate TGFbetaRII promoter activity. Panc1 cells were transfected with KLF14(FLAG) and Sp1(His) epitope-tagged expression constructs or control empty vector as indicated to evaluate in vivo competition on TGFbetaRII promoter activity. Western control (FLAG/His) is shown for epitope-tagged expression. Data are the mean +/- S.D. from three independent experiments, each done in triplicate. B, KLF14 binds to four of the putative Sp1 sites and competes with Sp1 on the TGFbetaRII promoter. Electromobility shift assay was performed using KLF14-ZF GST fusion proteins and radiolabeled oligonucleotides for each of the five putative Sp1 sites. Lane 1: control-Sp1 consensus oligonucleotide; lane 2: control-Sp1 mutant oligonucleotide; lane 3: Sp1 consensus oligonucleotide and rhSP1 protein; lane 4: WT oligonucleotide; lane 5: mut#1 oligonucleotide; lane 6: mut#2 oligonucleotide; lane 7: WT oligonucleotide and 25x cold probe; lane 8: WT oligonucleotide and 100x cold probe; lane 9: WT oligonucleotide and anti-GST; lane 10: WT oligonucleotide and 1x rhSp1 protein; lane 11: WT oligonucleotide and 5x rhSp1 protein. KLF14 band (open arrowhead). Sp1 band (closed arrowhead). The depicted blots are representative of triplicate experiments. C, KLF14 utilizes four Sp/KLF sites to repress the TGFbetaRII promoter in vivo. Panc1 cells were transfected with TGFbetaRII-luciferase with mutated Sp1 sites as indicated and stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation, and transcriptional activity was measured and normalized to control empty vector. Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment.
###end p 43
###begin p 44
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 44 47 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 212 219 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 235 238 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 242 245 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 420 421 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 498 501 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 505 508 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 671 677 660 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 718 724 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 762 768 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 819 825 808 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 847 853 836 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 878 884 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 909 915 898 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 956 962 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
###xml 1004 1010 993 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 9</italic>
###xml 1045 1052 1034 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 10</italic>
###xml 1095 1102 1084 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 11</italic>
###xml 1157 1171 1146 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open arrowhead</italic>
###xml 1184 1200 1173 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed arrowhead</italic>
###xml 1216 1221 1205 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blots</italic>
###xml 1268 1269 1257 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1319 1322 1308 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1326 1329 1312 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1339 1346 1325 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1382 1385 1368 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1389 1392 1372 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
A, KLF14 and Sp1 compete to regulate TGFbetaRII promoter activity. Panc1 cells were transfected with KLF14(FLAG) and Sp1(His) epitope-tagged expression constructs or control empty vector as indicated to evaluate in vivo competition on TGFbetaRII promoter activity. Western control (FLAG/His) is shown for epitope-tagged expression. Data are the mean +/- S.D. from three independent experiments, each done in triplicate. B, KLF14 binds to four of the putative Sp1 sites and competes with Sp1 on the TGFbetaRII promoter. Electromobility shift assay was performed using KLF14-ZF GST fusion proteins and radiolabeled oligonucleotides for each of the five putative Sp1 sites. Lane 1: control-Sp1 consensus oligonucleotide; lane 2: control-Sp1 mutant oligonucleotide; lane 3: Sp1 consensus oligonucleotide and rhSP1 protein; lane 4: WT oligonucleotide; lane 5: mut#1 oligonucleotide; lane 6: mut#2 oligonucleotide; lane 7: WT oligonucleotide and 25x cold probe; lane 8: WT oligonucleotide and 100x cold probe; lane 9: WT oligonucleotide and anti-GST; lane 10: WT oligonucleotide and 1x rhSp1 protein; lane 11: WT oligonucleotide and 5x rhSp1 protein. KLF14 band (open arrowhead). Sp1 band (closed arrowhead). The depicted blots are representative of triplicate experiments. C, KLF14 utilizes four Sp/KLF sites to repress the TGFbetaRII promoter in vivo. Panc1 cells were transfected with TGFbetaRII-luciferase with mutated Sp1 sites as indicated and stimulated with 10 ng/ml TGFbeta1 after overnight serum starvation, and transcriptional activity was measured and normalized to control empty vector. Data are the mean +/- S.D. from three independent experiments, with triplicates for each experiment.
###end p 44
###begin p 45
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 87 99 84 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII in vitro</italic>
###xml 164 165 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 158 165 155 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 205 206 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 199 206 196 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 562 563 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 556 563 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 563 574 560 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lanes 1&#8211;3</italic>
###xml 688 692 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">#1&#8211;3</italic>
###xml 697 698 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 816 817 813 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 810 817 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 817 826 814 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lanes 7</italic>
###xml 831 832 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 1012 1013 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1006 1013 1003 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1013 1021 1010 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lane 9</italic>
###xml 1150 1151 1147 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1144 1151 1141 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1151 1160 1148 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lanes 5</italic>
###xml 1165 1166 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1242 1248 1239 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 1353 1359 1350 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 1599 1600 1596 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1593 1600 1590 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1600 1610 1597 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lanes 10</italic>
###xml 1615 1617 1612 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">11</italic>
###xml 1670 1677 1667 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1685 1686 1682 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1679 1686 1676 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
Thus, to first delineate the DNA binding properties of KLF14 to the promoter of TGFbetaRII in vitro, we characterize the five putative Sp/KLF sites (shown in Fig. 1B) by electromobility shift assay (Fig. 5B). In this experiment, radiolabeled oligonucleotides for each of the 5 Sp1 sites have been created as well as mutants for each site containing either 2- or 4-nucleotide substitutions (mut#1 or mut#2, respectively) within the GC-rich binding sequence. Sp1-consensus oligonucleotides and respective mutants have been used as internal binding controls (Fig. 5B, lanes 1-3). The interaction between a recombinant KLF14 zinc finger DNA-binding domain and four of the Sp/KLF site probes (#1-3 and 5) is specific as indicated by the fact that an excess of unlabeled probe competes with the radiolabeled probes (Fig. 5B, lanes 7 and 8). Furthermore, we were able to abolish this binding by using antibodies against the recombinant KLF protein (anti-GST antibody), thus confirming specificity of the complex (Fig. 5B, lane 9). Further specificity is evidenced by the impaired ability of recombinant KLF14 protein to bind to mutated Sp/KLF probes (Fig. 5B, lanes 5 and 6). Visible but reduced binding is noted with the 2-bp mutant probes (mut#1, lane 5) for sites #1-3, however a significant loss of binding was observed with the 4-bp mutant probes (mut#2, lane 6) at all sites. Moreover, through addition of recombinant Sp1 protein to the reaction, an increase in the concentration of Sp1 diminished the binding of KLF14, demonstrating that KLF14 and Sp1 compete for these GC-rich binding sites (Fig. 5B, lanes 10 and 11), complementing the competition results we observed in vivo (Fig. 5A). Only a weak complex was visualized with site #4, indicating that this site was less specific for KLF14 binding than the other four sites.
###end p 45
###begin p 46
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 67 70 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 277 278 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 271 278 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 366 369 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 373 376 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 894 895 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 888 895 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 978 981 969 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 985 988 973 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
To functionally complement these studies, we have performed TGFbetaRII reporter assays with both wild-type and mutant promoter-luciferase constructs. Site-directed mutagenesis has been utilized to create a 2-nucleotide substitution in each of the 5 GC-rich Sp/KLF sites (Fig. 5C). These assays resulted in a marked loss of the repression observed with the wild-type TGFbetaRII promoter upon KLF14 overexpression with mutation in Sp/KLF sites #1, 2, 3, and 5, particularly with a significant gain of transcriptional activity upon mutating site #1. These findings demonstrate that these four are operational to silence the transcriptional activity of the TGFbetaRII promoter by KLF14. Furthermore, we did not observe a significant loss of repression with mutation of site #4 with KLF14 overexpression, which supports our finding of negligible binding of KLF14 to this specific Sp/KLF site (Fig. 5B). All together, KLF14 appears to bind and act on four of the GC-rich sites of the TGFbetaRII promoter to repress its transcriptional activity, and this occurs through a mechanism that includes, at least in part, competition with Sp1.
###end p 46
###begin p 47
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Repression of the TGF</italic>
###xml 25 102 22 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII Gene by KLF14 Occurs via Mechanisms Involving Chromatin-modifying Enzymes</italic>
###xml 283 284 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 277 284 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 423 425 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 427 429 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 536 539 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 543 546 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 683 685 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 687 689 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 933 934 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 927 934 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1179 1182 1173 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1186 1189 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1199 1206 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1270 1273 1261 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1277 1280 1265 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1297 1298 1285 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1291 1298 1279 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1364 1365 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1358 1365 1346 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1435 1438 1420 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1442 1445 1424 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1695 1696 1671 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1689 1696 1665 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 1972 1975 1948 1951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1979 1982 1952 1955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 2188 2189 2158 2159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2182 2189 2152 2159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 2269 2271 2239 2241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 2387 2388 2354 2355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2381 2388 2348 2355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 2471 2473 2438 2440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 2521 2524 2488 2491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 2528 2531 2492 2495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 2694 2697 2655 2658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 2701 2704 2659 2662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 2743 2744 2701 2702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2749 2750 2707 2708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2735 2750 2693 2708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>C</italic> and <italic>D</italic></xref>
###xml 3112 3118 3070 3076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
Repression of the TGFbetaRII Gene by KLF14 Occurs via Mechanisms Involving Chromatin-modifying Enzymes-Careful examination of KLF14 sequence reveals a 26-amino acid domain that is highly similar to repression domains of KLF9 (BTEB1), KLF13 (BTEB3), and KLF16 (BTEB4) proteins (Fig. 6A), which we have previously shown to repress transcription by recruiting Sin3a via its paired amphipathic helix 2 domain, as well as HDAC (15, 28). Interestingly, other studies have found that HDAC inhibition leads to transcriptional activation of the TGFbetaRII promoter in various cancer cell lines, raising the possibility that a repressor of this type may be operational to achieve this effect (29, 30). Thus, we have tested whether KLF14 does indeed interact with Sin3a and HDAC by immunoprecipitating full-length FLAG-tagged KLF14 from PANC1 cells. The presence of Sin3a and HDAC complexed to KLF14 is detected by Western-blot analysis (Fig. 6B). Thus, these results indicate that KLF14 interacts with Sin3a and HDAC in mammalian cells, implying that these proteins are part of a repressor complex. Subsequently, we have investigated whether this repressor complex occupies the endogenous TGFbetaRII promoter in vivo via ChIP assays. First, we find that KLF14 indeed binds to the TGFbetaRII promoter (Fig. 6C). Moreover, congruent with our data using promoter assays (Fig. 6C), treatment with TGFbeta1 increases the amount of KLF14 bound to the TGFbetaRII promoter. In addition, the treatment with TGFbeta1 coincides with the appearance of Sin3a on the same region of the promoter as KLF14, further implicating this repressor complex in the mechanism of KLF14 repression of the TGFbetaRII promoter (Fig. 6D). To gain insight into the type of chromatin remodeling that accompanies KLF14 and Sin3a occupation, we also have performed ChIP using antibodies to various histone marks. Interestingly, we find that, under native conditions, acetylated histones H3 and H4 are present on the TGFbetaRII promoter; however, upon TGFbeta1 treatment, these fall to negligible levels, indicating a change from a transcriptionally "active," acetylated state to a relatively "inactive," non-acetylated state (Fig. 6D). Moreover, we observe that, although methylated K20 H4, a mark of repression (31), is not present under native conditions, it occupies the promoter upon TGFbeta1 treatment along with Sin3a (Fig. 6D). These types of experiments are in agreement with the "histone code hypothesis" (32), revealing that the state of chromatin in the TGFbetaRII promoter appears to switch from "active" to "repressed" upon KLF14 occupation after treatment with TGFbeta1, all consistent with the idea that KLF14 binds to the TGFbetaRII promoter to cause repression (Fig. 6, C and D). Therefore, both competition with Sp1 and direct repression via the N-terminal domain, are likely to behave as a dual mechanism of repression that would make it more difficult to reverse than if one of them was operational. This redundancy would ensure that the promoter remains silent even under circumstances that inactivate either of the single mechanisms (Fig. 7).
###end p 47
###begin p 48
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WCE</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 464 467 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 477 484 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 644 647 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 651 654 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 754 757 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 761 764 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 809 814 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-FLAG</italic>
###xml 857 861 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mock</italic>
###xml 891 896 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">input</italic>
###xml 923 926 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 930 933 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 973 974 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1058 1061 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1065 1068 1043 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 9 1233 9 1208 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><italic>A</italic>, alignment displaying the 26-amino acid Sin3-interacting domain of KLF14 similar to other KLF repressors, KLF9, KLF13, and KLF16. <italic>B</italic>, HDAC2 and mSin3a form a complex with KLF14 <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and FLAG-immunoprecipitated. Immunoprecipitated complexes were then probed with antibodies against various known corepressors. <italic>WCE</italic>, whole cell extract. <italic>C</italic>, KLF14 occupies the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and subject to chromatin immunoprecipitation. A 263-bp fragment of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified by PCR from anti-FLAG or mock immunoprecipitated DNA samples. Note that the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified from anti-FLAG (&#945;<italic>-FLAG</italic>) but not mock immunoprecipitated samples (<italic>mock</italic>) transfected with KLF14. The <italic>input</italic> shows the presence of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter prior to immunoprecipitation. <italic>D</italic>, TGF&#946;1 leads to repressive chromatin modifications upon KLF14 occupation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Panc1 cells were transfected with FLAG-tagged KLF14 and treated with TGF&#946;1 and chromatin landscape ChIP assay was performed using specified antibodies.</p>
###xml 9 1233 9 1208 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49"><italic>A</italic>, alignment displaying the 26-amino acid Sin3-interacting domain of KLF14 similar to other KLF repressors, KLF9, KLF13, and KLF16. <italic>B</italic>, HDAC2 and mSin3a form a complex with KLF14 <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and FLAG-immunoprecipitated. Immunoprecipitated complexes were then probed with antibodies against various known corepressors. <italic>WCE</italic>, whole cell extract. <italic>C</italic>, KLF14 occupies the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and subject to chromatin immunoprecipitation. A 263-bp fragment of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified by PCR from anti-FLAG or mock immunoprecipitated DNA samples. Note that the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified from anti-FLAG (&#945;<italic>-FLAG</italic>) but not mock immunoprecipitated samples (<italic>mock</italic>) transfected with KLF14. The <italic>input</italic> shows the presence of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter prior to immunoprecipitation. <italic>D</italic>, TGF&#946;1 leads to repressive chromatin modifications upon KLF14 occupation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Panc1 cells were transfected with FLAG-tagged KLF14 and treated with TGF&#946;1 and chromatin landscape ChIP assay was performed using specified antibodies.</p></caption>
###xml 1233 1233 1208 1208 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890006"/>
###xml 0 1233 0 1208 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="49"><italic>A</italic>, alignment displaying the 26-amino acid Sin3-interacting domain of KLF14 similar to other KLF repressors, KLF9, KLF13, and KLF16. <italic>B</italic>, HDAC2 and mSin3a form a complex with KLF14 <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and FLAG-immunoprecipitated. Immunoprecipitated complexes were then probed with antibodies against various known corepressors. <italic>WCE</italic>, whole cell extract. <italic>C</italic>, KLF14 occupies the <italic>TGF</italic>&#946;<italic>RII</italic> promoter <italic>in vivo</italic>. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and subject to chromatin immunoprecipitation. A 263-bp fragment of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified by PCR from anti-FLAG or mock immunoprecipitated DNA samples. Note that the <italic>TGF</italic>&#946;<italic>RII</italic> promoter was amplified from anti-FLAG (&#945;<italic>-FLAG</italic>) but not mock immunoprecipitated samples (<italic>mock</italic>) transfected with KLF14. The <italic>input</italic> shows the presence of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter prior to immunoprecipitation. <italic>D</italic>, TGF&#946;1 leads to repressive chromatin modifications upon KLF14 occupation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter. Panc1 cells were transfected with FLAG-tagged KLF14 and treated with TGF&#946;1 and chromatin landscape ChIP assay was performed using specified antibodies.</p></caption><graphic xlink:href="zbc0110966890006"/></fig>
FIGURE 6.A, alignment displaying the 26-amino acid Sin3-interacting domain of KLF14 similar to other KLF repressors, KLF9, KLF13, and KLF16. B, HDAC2 and mSin3a form a complex with KLF14 in vivo. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and FLAG-immunoprecipitated. Immunoprecipitated complexes were then probed with antibodies against various known corepressors. WCE, whole cell extract. C, KLF14 occupies the TGFbetaRII promoter in vivo. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and subject to chromatin immunoprecipitation. A 263-bp fragment of the TGFbetaRII promoter was amplified by PCR from anti-FLAG or mock immunoprecipitated DNA samples. Note that the TGFbetaRII promoter was amplified from anti-FLAG (alpha-FLAG) but not mock immunoprecipitated samples (mock) transfected with KLF14. The input shows the presence of the TGFbetaRII promoter prior to immunoprecipitation. D, TGFbeta1 leads to repressive chromatin modifications upon KLF14 occupation of the TGFbetaRII promoter. Panc1 cells were transfected with FLAG-tagged KLF14 and treated with TGFbeta1 and chromatin landscape ChIP assay was performed using specified antibodies.
###end p 48
###begin p 49
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WCE</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 455 458 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 468 475 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 635 638 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 642 645 636 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 745 748 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 752 755 743 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 800 805 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-FLAG</italic>
###xml 848 852 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mock</italic>
###xml 882 887 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">input</italic>
###xml 914 917 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 921 924 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 964 965 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1049 1052 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1056 1059 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
A, alignment displaying the 26-amino acid Sin3-interacting domain of KLF14 similar to other KLF repressors, KLF9, KLF13, and KLF16. B, HDAC2 and mSin3a form a complex with KLF14 in vivo. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and FLAG-immunoprecipitated. Immunoprecipitated complexes were then probed with antibodies against various known corepressors. WCE, whole cell extract. C, KLF14 occupies the TGFbetaRII promoter in vivo. Panc1 cells were transfected with FLAG-tagged KLF14 or control empty vector constructs and subject to chromatin immunoprecipitation. A 263-bp fragment of the TGFbetaRII promoter was amplified by PCR from anti-FLAG or mock immunoprecipitated DNA samples. Note that the TGFbetaRII promoter was amplified from anti-FLAG (alpha-FLAG) but not mock immunoprecipitated samples (mock) transfected with KLF14. The input shows the presence of the TGFbetaRII promoter prior to immunoprecipitation. D, TGFbeta1 leads to repressive chromatin modifications upon KLF14 occupation of the TGFbetaRII promoter. Panc1 cells were transfected with FLAG-tagged KLF14 and treated with TGFbeta1 and chromatin landscape ChIP assay was performed using specified antibodies.
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 268 271 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 275 278 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
The current study provides us with several novel mechanistic insights on the regulation of the TGFbeta pathway. For instance, the data reported here represent the first functional characterization of the KLF14 protein, outline a novel pathway for the silencing of the TGFbetaRII promoter, provide insight into the molecular mechanisms by which these phenomena are achieved, and report additional TGFbeta-inducible, KLF proteins that are good candidates to regulate this promoter. These findings are of significant relevance to the areas of KLF proteins, TGFbeta signaling, the maintenance of cell homeostasis, and their potential contribution to disease states.
###end p 51
###begin p 52
###xml 255 257 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 365 367 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 394 396 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 643 651 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 834 836 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 896 899 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 903 906 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
TGFbeta1 ligand itself may play a role in regulating signaling by down-regulating the cell surface receptor and thus abrogating downstream messages. Others have also shown that the TGFbeta receptors are under autoregulation control by ligand stimulation (18). It has been previously shown that treatment with TGFbeta1 leads to down-regulation of TGFbetaRII levels (19). Derynck and colleagues (20) have previously described a process in osteoblastic differentiation in which at first there is a marked up-regulation of TGFbeta1 and sensitivity followed by marked down-regulation of receptors and insensitivity to TGFbeta1. Furthermore, recent in vitro studies on the biosynthesis of the receptors indicate that the half-life of TGFbetaRII is approximately60 min and is further reduced to 45 min in the presence of exogenous TGFbeta1 (33). Therefore, understanding how this down-regulation of the TGFbetaRII promoter occurs is of primary biological importance for better understanding TGFbeta signaling.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 54 9 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of KLF14-mediated TGF&#946;RII silencing.</bold>
###xml 151 154 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 158 161 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 255 260 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 273 274 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 311 314 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 318 321 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 358 359 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 382 383 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 421 422 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 554 555 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 9 675 9 651 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Model of KLF14-mediated TGF&#946;RII silencing.</bold> Activation of the TGF&#946;RII would occur via TGF&#946;1 ligand initiating an up-regulation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter by Sp1. In our model, activation of the TGF&#946; pathway also causes an induction of <italic>KLF14</italic> expression (<italic>A</italic>), which would, in turn, bind to the <italic>TGF</italic>&#946;<italic>RII</italic> promoter through its GC-rich sites (<italic>B</italic>), competing away Sp1 (<italic>C</italic>), recruiting the Sin3a/HDAC complex (<italic>D</italic>), and remodeling chromatin from a transcriptionally &#8220;active,&#8221; acetylated state to an &#8220;inactive&#8221; state with silencing methyl marks (<italic>E</italic>). Thus, KLF14 mediates a negative feedback loop to down-regulate the type II TGF&#946; receptor upon TGF&#946; stimulation.</p>
###xml 9 675 9 651 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Model of KLF14-mediated TGF&#946;RII silencing.</bold> Activation of the TGF&#946;RII would occur via TGF&#946;1 ligand initiating an up-regulation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter by Sp1. In our model, activation of the TGF&#946; pathway also causes an induction of <italic>KLF14</italic> expression (<italic>A</italic>), which would, in turn, bind to the <italic>TGF</italic>&#946;<italic>RII</italic> promoter through its GC-rich sites (<italic>B</italic>), competing away Sp1 (<italic>C</italic>), recruiting the Sin3a/HDAC complex (<italic>D</italic>), and remodeling chromatin from a transcriptionally &#8220;active,&#8221; acetylated state to an &#8220;inactive&#8221; state with silencing methyl marks (<italic>E</italic>). Thus, KLF14 mediates a negative feedback loop to down-regulate the type II TGF&#946; receptor upon TGF&#946; stimulation.</p></caption>
###xml 675 675 651 651 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0110966890007"/>
###xml 0 675 0 651 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="54"><bold>Model of KLF14-mediated TGF&#946;RII silencing.</bold> Activation of the TGF&#946;RII would occur via TGF&#946;1 ligand initiating an up-regulation of the <italic>TGF</italic>&#946;<italic>RII</italic> promoter by Sp1. In our model, activation of the TGF&#946; pathway also causes an induction of <italic>KLF14</italic> expression (<italic>A</italic>), which would, in turn, bind to the <italic>TGF</italic>&#946;<italic>RII</italic> promoter through its GC-rich sites (<italic>B</italic>), competing away Sp1 (<italic>C</italic>), recruiting the Sin3a/HDAC complex (<italic>D</italic>), and remodeling chromatin from a transcriptionally &#8220;active,&#8221; acetylated state to an &#8220;inactive&#8221; state with silencing methyl marks (<italic>E</italic>). Thus, KLF14 mediates a negative feedback loop to down-regulate the type II TGF&#946; receptor upon TGF&#946; stimulation.</p></caption><graphic xlink:href="zbc0110966890007"/></fig>
FIGURE 7.Model of KLF14-mediated TGFbetaRII silencing. Activation of the TGFbetaRII would occur via TGFbeta1 ligand initiating an up-regulation of the TGFbetaRII promoter by Sp1. In our model, activation of the TGFbeta pathway also causes an induction of KLF14 expression (A), which would, in turn, bind to the TGFbetaRII promoter through its GC-rich sites (B), competing away Sp1 (C), recruiting the Sin3a/HDAC complex (D), and remodeling chromatin from a transcriptionally "active," acetylated state to an "inactive" state with silencing methyl marks (E). Thus, KLF14 mediates a negative feedback loop to down-regulate the type II TGFbeta receptor upon TGFbeta stimulation.
###end p 53
###begin p 54
###xml 0 45 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of KLF14-mediated TGF&#946;RII silencing.</bold>
###xml 142 145 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 149 152 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 246 251 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 264 265 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 302 305 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 309 312 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 349 350 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 373 374 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 412 413 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 545 546 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
Model of KLF14-mediated TGFbetaRII silencing. Activation of the TGFbetaRII would occur via TGFbeta1 ligand initiating an up-regulation of the TGFbetaRII promoter by Sp1. In our model, activation of the TGFbeta pathway also causes an induction of KLF14 expression (A), which would, in turn, bind to the TGFbetaRII promoter through its GC-rich sites (B), competing away Sp1 (C), recruiting the Sin3a/HDAC complex (D), and remodeling chromatin from a transcriptionally "active," acetylated state to an "inactive" state with silencing methyl marks (E). Thus, KLF14 mediates a negative feedback loop to down-regulate the type II TGFbeta receptor upon TGFbeta stimulation.
###end p 54
###begin p 55
###xml 487 490 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 494 497 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 774 776 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 778 780 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 985 987 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1226 1231 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF14</italic>
###xml 1308 1311 1290 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1315 1318 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1586 1589 1562 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1593 1596 1566 1569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1647 1650 1620 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1654 1657 1624 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1479 1484 <span type="species:ncbi:9606">human</span>
In this regard, the current study reports several novel observations of significant biochemical relevance for extending our knowledge of TGFbeta signaling regulation by non-Smad proteins. For instance, this study represents the first functional characterization of KLF14 as a novel TGFbeta-inducible repressor protein that mediates silencing of the TGFbetaRII, and the mechanisms by which this phenomenon occurs, in particular the role of corepressors and chromatin modifications on the TGFbetaRII promoter. Previous promoter studies have primarily focused on the role of Sp1 in the activation of this promoter. However, recent studies have uncovered a paradoxical behavior for this promoter, namely that histone deacetylase inhibitors are needed to activate this promoter (34, 35). These data point to the existence of a repressive state of this promoter, which is less likely to be regulated by Sp1 but rather by Sp/KLF repressors of the type previously described by our laboratory (11). However, in the current study, rather than looking for a candidate gene within the family of KLF repressors, we have performed an unbiased screening for the TGFbeta inducibility of each of the 24 KLF transcription factors and find that KLF14 is up-regulated upon TGFbeta treatment and also can efficiently repress the TGFbetaRII. Interestingly, we demonstrate that there is a strong inverse correlation between expression patterns in a temporal manner of TGFbetaRII mRNA and KLF14 mRNA in human pancreatic cancer cells. Expression of exogenous KLF14 decreases the level of transcription from the TGFbetaRII promoter, implying a repressive role for KLF14 in TGFbetaRII expression.
###end p 55
###begin p 56
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 887 890 887 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 894 897 891 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1192 1195 1189 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1199 1202 1193 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
Further analysis reveals the mechanism by which this protein works, indicating that KLF14 is a member of the Sin3-dependent KLF repressors. This is important in light of there being two types of repressors in this family as recently reviewed by us (11), the Sin3a-dependent proteins, which include KLF9, -10, -11, -16, and now -14, and the CtBP-dependent proteins, such as KLF3 and -8. This knowledge can now be very useful for performing rapid screening of the proteins that may be acting as repressors of particular genes, besides the traditional HDAC inhibitor experiments. This screening, we propose, can utilize siRNA to either target CtBP or Sin3a. An abolition of the silencing activity would then rapidly focus the investigations on a reduced number of candidates belonging to each of these groups. In addition to the recruitment of a KLF14-mSin3A-HDAC2 repressor complex to the TGFbetaRII promoter, we observed a concurrent remodeling of chromatin, which involves loss of transcriptionally "active" acetylated histone marks and an increase in histone marks that associate with transcriptional silencing. Finally, we defined binding sites involved in KLF14-mediated repression of the TGFbetaRII promoter, namely sites -143/138 (#1), -101/-95 (#2), -59/52 (#3) and -11/-5 (#5), which are consistent with previously reported Sp1 sites, and these same sites, when mutated, lose the repressive effect of KLF14.
###end p 56
###begin p 57
###xml 359 360 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 541 542 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 544 546 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 679 682 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 686 689 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
###xml 1013 1019 1001 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1140 1143 1128 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF</italic>
###xml 1147 1150 1132 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RII</italic>
Overall, however, the major relevance of this study is the fact that it contributes to organize our thoughts on how TGFbeta signaling is regulated. It has recently been appropriately proposed to classify these mechanisms by whether they are directly mediated by Smads (the best studied to date) or those less understood events regulated by non-Smad proteins (4). In fact, our laboratory has previously described a role for KLF repressors, namely KLF10 (TIEG1) and KLF11 (TIEG2), as non-Smad effectors of the TGFbeta response in cell growth (9, 36). Now, due to the findings reported in the current study, we can propose a model wherein TGFbeta cytokines activate and repress the TGFbetaRII promoter using the very same GC-rich sites utilized by this family of proteins. Activation would occur in an initial phase via Sp1, whereas inhibition would follow activation and require the action of KLF14, competition of Sp1, recruitment of Sin3a, HDAC, and distinct chromatin modifications on the promoter (see model in Fig. 7). Therefore, KLF14 becomes another important non-Smad protein, in which at least one of its functions is to silence the TGFbetaRII. This novel transcriptional pathway thus becomes an important step for modulating the activity of TGFbeta signaling.
###end p 57
###begin title 58
Supplementary Material
###end title 58
###begin title 59
[Supplemental Data]
###end title 59
###begin p 60
###xml 215 216 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 243 244 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 320 321 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 108 111 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The abbreviations used are: TGFbeta, transforming growth factor-beta; TGFbetaRII, TGFbeta receptor type II; CMV, cytomegalovirus; RT, reverse transcription; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; B2M, beta2-microglobulin; TUBB2, beta2-Tubulin; HPRT1, hypoxanthine phosphoribosyltransferase 1; GST, glutathione S-transferase; HDAC, histone deacetylase; WT, wild type; KLF14, Kruppel-like factor 14; ChIP, chromatin immunoprecipitation.
###end p 60
###begin p 61
Reported by J. Kaczynski and R. Urrutia to NCBI, 2002.
###end p 61

